4.6 Article

Family History of Prostate Cancer and Survival Outcomes in the UK Genetic Prostate Cancer Study

Journal

EUROPEAN UROLOGY
Volume 83, Issue 3, Pages 257-266

Publisher

ELSEVIER
DOI: 10.1016/j.eururo.2022.11.019

Keywords

Prostate cancer; Family history; Survival; Screening; Awareness

Ask authors/readers for more resources

A family history of prostate cancer is associated with an increased risk of developing the disease. This study examines how the number, degree, and age of relatives with prostate cancer are related to overall survival and prostate cancer-specific survival in prostate cancer patients.
Background: A family history (FH) of prostate cancer (PrCa) is associated with an increased likelihood of PrCa diagnosis. Conflicting evidence exists regarding familial PrCa and clinical outcomes among PrCa patients, including all-cause mortality/overall survival (OS), PrCa-specific survival (PCSS), aggressive histology, and stage at diagnosis. Objective: To determine how the number, degree, and age of a PrCa patient's affected rel-atives are associated with OS and PCSS of those already diagnosed with PrCa. Design, setting, and participants: The UK Genetic Prostate Cancer Study is a longitudinal, multi-institutional, observational study collecting baseline and follow-up clinical data since 1992. We examined OS and PCSS in 16 340 men by degree and number of relatives with prostate and genetically related cancers (breast, ovarian, and colorectal). Outcome measurements and statistical analysis: The primary outcome was all-cause mortality among PrCa patients. The risk of death with respect to FH was assessed by cal-culating hazard ratios from Cox proportional hazard regression models, adjusting for rel-evant factors. Results and limitations: A stronger FH was inversely associated with the risk of all-cause and PrCa-specific mortality. This association was greater in those with an increasing number (p-trend < 0.001) and increasing closeness (p-trend < 0.001) of the diagnosed relatives. Patients with at least one first-degree relative were at a lower risk of all -cause mortality than those with no FH (hazard ratio = 0.82 [95% confidence interval 0.75-0.89]). The population is largely of European ancestry, and this may cause an issue with representation and generalisation. Data are missing on epidemiological risk factors for death such as smoking and on comorbidities. Recall of family members' diagnoses may affect the classification of FH in unconfirmed cases. Conclusions: Based on the investigation of the type and timing of relatives' cancers, it is likely that reductions in mortality are due almost completely to a greater awareness of

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available